Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Monday 05 March, 2018

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 7057G
GlaxoSmithKline PLC
05 March 2018
 

GlaxoSmithKline plc (the 'Company')

 

Transaction notification

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr B McNamara

b)

Position/status

CEO, GSK Consumer Healthcare

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

American Depositary Shares ('ADSs')

 

ISIN: US37733W1053

 

b)

Nature of the transaction

Following the vesting on 2 March 2018 of an award made on 2 March 2015 under the GlaxoSmithKline Deferred Investment Award Plan, Mr McNamara will receive a cash payment of $684,709.84 less applicable tax withholding in respect of 18,967.031 notional ADSs.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

$36.10

18,967.031

 

d)

Aggregated information

 

Aggregated volume Price

n/a (single transaction)

 

e)

Date of the transaction

2018-03-02

f)

Place of the transaction

 

n/a

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLELFBVXFBBBL

a d v e r t i s e m e n t